AVIEW vs Stethee Pro 1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AVIEW

by Coreline Soft Co.

Stethee Pro 1

by M3DICINE

AI Verdict

AVIEW is an AI platform designed for comprehensive analysis of CT scans to detect and monitor lung and cardiac conditions, focusing on detailed imaging diagnostics. In contrast, Stethee Pro 1 is an AI-enabled digital stethoscope system that provides real-time cardiac and respiratory vital sign analysis through auscultation. While both leverage AI in cardiology and pulmonology, they serve different diagnostic modalities and clinical workflows, making them complementary rather than directly competitive.

Choose AVIEW if…

Choose AVIEW if your institution requires a comprehensive AI-driven platform for detailed analysis of CT scans, specifically for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification. It is ideal for radiology departments and pulmonology specialists seeking to enhance diagnostic precision, automate segmentation, and streamline workflows for complex imaging studies and follow-up protocols.

View AVIEW →

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you need a portable, AI-enabled wireless digital stethoscope for real-time cardiac and respiratory vital sign analysis, particularly in telemedicine, remote monitoring, or emergency settings. This tool is best suited for clinicians requiring immediate, on-the-spot assessments with advanced sound amplification and secure data sharing capabilities, without the need for extensive imaging infrastructure.

View Stethee Pro 1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AVIEW	Stethee Pro 1
Pricing	Subscription; one-off payment	$499 usd
Deployment	Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)	Cloud, Mobile
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Stethee Pro 1

Stethee Pro 1 offers a highly portable, real-time diagnostic experience via a mobile app, making it intuitive for point-of-care use and telemedicine. The immediate visual and auditory feedback simplifies operation for clinicians across various settings. AVIEW focuses on seamless integration into existing radiology workflows and provides comprehensive reports, which is valuable but less immediately intuitive for a broad range of clinicians.

Clinical Value

AVIEW

AVIEW provides deep, quantitative diagnostic insights from CT scans for critical conditions like lung cancer, COPD, and coronary artery disease, directly impacting early detection and long-term patient management. Its comprehensive analysis capabilities offer significant diagnostic precision for complex diseases. Stethee Pro 1 delivers real-time cardiac and respiratory vital sign analysis and enhanced auscultation, valuable for immediate patient assessment, but its scope is more focused on immediate physiological data rather than comprehensive disease diagnosis from imaging.

Pricing & Value

Stethee Pro 1

Stethee Pro 1 offers a transparent and accessible pricing model with a clear upfront device cost of $499 and a separate subscription for advanced AI analytics. This model is more appealing for individual practitioners or smaller clinics seeking immediate value. AVIEW employs a subscription or one-off payment model based on installations and users, which is typical for enterprise software but lacks immediate transparency for individual users.

Enterprise Readiness

AVIEW

AVIEW demonstrates strong enterprise readiness through its diverse deployment options (cloud, hybrid, on-premise, virtualized) and explicit integration capabilities with PACS/RIS/CIS, which are critical for large healthcare IT infrastructures. Stethee Pro 1, while HIPAA compliant and cloud-enabled, primarily deploys via mobile app and web portal, suggesting a more distributed model that may require more effort for large-scale enterprise system integration.

Innovation

Stethee Pro 1

Stethee Pro 1 innovates by transforming a traditional stethoscope into an AI-enabled, wireless device offering real-time vital sign analysis, sophisticated sound filtering, and environmental data tagging. This represents a novel application of AI to a ubiquitous medical instrument for enhanced point-of-care diagnostics. AVIEW showcases innovation through its advanced AI algorithms for multi-organ analysis of CT scans, pushing the boundaries of diagnostic imaging interpretation, but Stethee Pro 1's approach is more disruptive to an established tool.

Support & Docs

Stethee Pro 1

Based on web search, M3DICINE's website for Stethee Pro 1 features a dedicated 'Support' section, including FAQs and user manuals, indicating a more structured and readily available resource for users. The provided facts for AVIEW do not detail support or documentation, and a quick web search did not immediately reveal a dedicated, publicly accessible support portal or extensive documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AVIEW	Stethee Pro 1
Product Name	AVIEW	Stethee Pro 1
Primary Use Case	Comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.	Real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing for enhanced diagnostics and telemedicine via an AI-enabled wireless digital stethoscope system.
Company	Coreline Soft Co.	M3DICINE Pty Ltd.
Target Medical Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Emergency Medicine, Pulmonology
Core AI Functionality	AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score); Emphysema quantification and low attenuation area (LAA) analysis; Coronary artery calcium (CAC) scoring.	AI-enabled wireless digital stethoscope system; Captures cardiac and respiratory vital signs in 20 seconds; Measures systole, diastole, heart cycle durations, and respiration rate.
Primary Data Source	CT scans	Cardiac and respiratory vital signs captured by a wireless digital stethoscope

Videos

Demos, reviews, and walkthroughs featuring AVIEW and Stethee Pro 1.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems, particularly for data transfer and reporting?

AVIEW is designed for workflow automation and integrates with PACS/RIS/CIS, streamlining radiology workflows and generating comprehensive PDF reports. Stethee Pro 1, with its mobile app and Central Web Portal, allows for secure data capture, analysis, recording, playback, and sharing, with the ability to generate and save patient vital sign reports directly into an EHR.

What clinical validation or performance metrics are available to demonstrate the accuracy and sensitivity of each tool's AI analysis?

AVIEW has demonstrated high detection sensitivity for lung nodules, with one study showing 99.8% sensitivity for lung cancer detection and another indicating radiologists using AVIEW 2.0 achieved an 89% increase in case throughput and 60% reduction in interpretation time. Stethee Pro 1's AI algorithms are clinically validated to accurately measure systole, diastole, heart cycle durations, and respiration rate in 20 seconds, with respiration rate detection showing 99.9% correlation with capnography.

Given their distinct functionalities, in which specific clinical scenarios or patient populations would each tool provide the most significant diagnostic advantage?

AVIEW offers a significant advantage in radiology for detailed diagnosis and long-term monitoring of lung conditions, including lung cancer, COPD, and coronary artery calcification from CT scans, especially for in-depth diagnostic evaluations. Stethee Pro 1 is most advantageous for real-time, point-of-care cardiac and respiratory vital sign analysis, enhancing diagnostics and telemedicine, and is particularly useful for quick screenings and remote monitoring.

What is the typical learning curve for physicians and their teams to effectively utilize each tool's advanced features and integrate them into daily practice?

AVIEW emphasizes streamlining radiology workflows and automated reporting, suggesting a focus on integrating into existing radiologist practices, with upgrades in UI/UX to enhance data extraction and communication. Stethee Pro 1 is designed for ease of use with its portable, wireless design and intuitive mobile and web applications, enabling quick vital sign capture, though mastering its advanced AI-driven analytics may require some learning.

What kind of ongoing technical and clinical support is provided, and are there opportunities to connect with existing users for peer insights?

Coreline Soft provides customer service and overseas business department contacts for AVIEW, indicating direct support channels. M3DICINE offers support for Stethee Pro through categories like Getting Started, Hardware, and Software, with popular articles for common queries. While direct peer connection opportunities aren't explicitly detailed, both companies provide avenues for support.

What are the key considerations for implementing each tool across multiple clinical sites or departments, and what is the estimated time-to-value for seeing tangible benefits?

AVIEW has processed over 2.5 million cases across 19 countries and is integrated into major U.S. medical centers, demonstrating its scalability and adaptability to real-world hospital operations, with clinical validation showing significant reductions in interpretation time. Stethee Pro 1's mobile and cloud-based nature makes it versatile for various enterprise healthcare settings, including telemedicine, and a usability study showed it could save over 2 hours per day for cardiologists examining 30 patients.